In the US, Nelarabine (nelarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia and Lymphoma.
US matches:
- Nelarabine
- Nelarabine Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01BB07
CAS registry number (Chemical Abstracts Service)
0121032-29-9
Chemical Formula
C11-H15-N5-O5
Molecular Weight
297
Therapeutic Categories
Antineoplastic agent
Antimetabolite
Chemical Names
2-Amino-ß-D-arabinofuranosyl-6-methoxy-9H-purine (WHO)
9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine (USAN)
9-(ß-D-Arabinofuranosyl)-6-methoxypurin-2-amin (IUPAC)
Foreign Names
- Nelarabinum (Latin)
- Nelarabin (German)
- Nelarabine (French)
- Nelarabina (Spanish)
Generic Names
- Nelarabine (OS: BAN, USAN)
- 506U (IS)
- 506U78 (IS)
- GW 506U78 (IS)
- MAY (IS: GlaxoWellcome)
- Nelzarabine (IS)
- NSC-686673 (IS)
- U78 (IS)
Brand Names
- Arranon
GlaxoSmithKline, United States - Atriance
Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Italy; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment